Pan-cancer analysis identifies KANSL2 as a cell-cycle–associated regulator of tumor progression and immunity in liver hepatocellular carcinoma
Nanbin Liu, Kun Li, Junqiao Feng, Shan Wang, Ji Li, Wenbin Yang, Senyang Li, Keping Feng · 2026
Read Pan-cancer analysis identifies KANSL2 as a cell-cycle–associated regulator of tumor progression and immunity in liver hepatocellular carcinoma by Nanbin Liu, Kun Li, Junqiao Feng, Shan Wang, Ji Li, Wenbin Yang, Senyang Li, Keping Feng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13569553.txt.
Description
Nanbin Liu and colleagues analyze, in a 2026 pan-cancer study, a gene called KANSL2 that helps control which genes are switched on. They ask how it behaves across cancers and especially in liver cancer. Public data on expression, outcomes, mutations, and immune patterns were combined with laboratory tests that silenced the gene in liver cancer cells.
The gene was switched on more strongly across many cancers and linked to worse outlook, most clearly in liver cancer. Its partners clustered around cell division, and immune signals in tumors shifted alongside it. Silencing slowed cell growth, movement, and invasion and stalled division. The gene looks like a useful marker and a possible drug target in liver cancer.
Catalog record
| CREATOR | Nanbin Liu, Kun Li, Junqiao Feng, Shan Wang, Ji Li, Wenbin Yang, Senyang Li, Keping Feng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |